Abdullah Beyoğlu

Dr. Abdullah Beyoğlu

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2020 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
ABAbdullah Beyoğlu
Abdullah Beyoğlu
YKYalcin Karakucuk
Yalcin Karakucuk
AÇAyşegül Çömez
Ayşegül Çömez

8 January 2025 in PeerJ
Verified
Journal Article
Open access
PDF file
MSMuhammed Seyithanoğlu
Muhammed Seyithanoğlu
SMSelma Meşen
Selma Meşen
ACAysegul Comez
Aysegul Comez
AMAli Meşen
Ali Meşen
ABAbdullah Beyoğlu
Abdullah Beyoğlu
FBFiliz Alkan Baylan
Filiz Alkan Baylan
Background: The aim of this study is to examine the relationship between elabela (ELA), a recently identified peptide also known as Toddler and Apela, and diabetic retinopathy (DR). ELA, produced in various tissues, acts as a natural ligand for the apelin receptor (APJ). Upon reviewing the existing literature, only one study was found investigating ELA, one of the APJ ligands, in the pathogenesis of DR. Methods: In our study the patient group comprising individuals diagnosed with type 2 diabetes mellitus (DM), categorized into three subgroups based on detailed fundus examination: those without DR (non-DR) (n = 20), non-proliferative DR (NPDR) (n = 20), and proliferative DR (PDR) (n = 20). A control group (n = 20) consisted of individuals without DM. Blood samples were collected during outpatient clinic admission to measure serum ELA levels, which were determined using a commercial ELISA kit. Results: The age, sex, and body mass index of the between groups were similar (p = 0.905, 0.985 and 0.241, respectively). The HbA1c levels of the between DM subgroups were similar (p = 0.199). Serum ELA levels were 217.19 ± 97.54 pg/mL in the non-DR group, 221.76 ± 93.12 pg/mL in the NPDR group, 302.35 ± 146.17 pg/mL in the PDR group and 216.49 ± 58.85 pg/mL in the control group. While ELA levels were higher in DM patients compared to the control group, this elevation did not reach statistical significance. Further analysis dividing DM patients into subgroups (non-DR, NPDR, and PDR) revealed higher ELA levels in the PDR group compared to the other subgroups, but this increase was not statistically significant. Conclusion: Despite the absence of a significant difference in our study, the identification of elevated ELA levels in the PDR group offers valuable insights for future investigations exploring the association between DR and ELA.

1 January 2022 in Arquivos Brasileiros de Oftalmologia
Verified
Journal Article
Open access
ABAbdullah Beyoğlu
Abdullah Beyoğlu
EKErgül Belge Kurutaş
Ergül Belge Kurutaş
YKYalçın Karaküçük
Yalçın Karaküçük
AÇAyşegül Çömez
Ayşegül Çömez
AMAli Meşen
Ali Meşen
| Purpose: This study aimed to determine the effect of serum G receptor-mediated protein-1 levels on the development of retinopathy in patients with diabetes in comparison with healthy individuals. Methods: The study enrolled patients with diabetic retinopathy (Group 1), patients without diabetic retinopathy (Group 2), and healthy individuals (Group 3). Levels of serum progesterone, serum G receptor-mediated protein-1, estradiol, oxidant/antioxidants, and thyroid-releasing hormones were analyzed and compared among the groups. Post-hoc analysis was performed to compare the subgroups in which significant differences were found. Results: Groups 1, 2, and 3 each included 40 patients. A significant difference was found among all groups in terms of serum G receptor-mediated protein-1, oxidant/antioxidant, and estradiol levels (p<0.01), but no significant difference was found in terms of thyroid-releasing hormone or progesterone (p=0.496, p=0.220, respectively). In the post-hoc analysis of the groups with significant differences, another significant difference was found among all groups for serum G receptor-mediated protein-1 and oxidant/antioxidant levels (p<0.05). Serum G receptor-mediated protein-1 and oxidant levels were positively correlated, whereas serum G receptor-mediated protein-1 and antioxidant levels were negatively correlated (r=0.622/p<0.01, r=0.453/p<0.01, r=0.460/p<0.01, respectively). The multiple regression analysis showed that increased levels of serum G receptor-mediated protein-1 may help prevent diabetic retinopathy. Conclusions: Serum G receptor-mediated protein-1 levels, which were the highest in the diabetic retinopathy Group, increased as the oxidant/antioxidant balance changed in favor of oxidative stress. This appears to be a defense mechanism for preventing neuronal damage.

23 September 2024 in Turkish Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
SMSelma Mesen
Selma Mesen
ACAysegul Comez
Aysegul Comez
AMAli Mesen
Ali Mesen
ABAbdullah Beyoğlu
Abdullah Beyoğlu
MSMuhammed Seyithanoğlu
Muhammed Seyithanoğlu
Objectives: Comparing serum and humor aqueous (HA) raftlin levels in diabetic patients and control group. Methods: In this prospective study, patients were divided into two groups diabetes mellitus (DM) and a control group. The DM group was divided into three subgroups. A total of 160 patients, including 35 without diabetic retinopathy (non-DR) (Group 1), 31 non-proliferative diabetic retinopathy (NPDR) (Group 2), 32 proliferative diabetic retinopathy (PDR) (Group 3), and 62 controls (Group 4), were included in the study. Venous blood and HA samples were taken from the patients and their raftlin levels were measured. Results: Serum raftlin levels were decreased in the DM main group (p=0.046) but there was no significant difference in HA raftlin levels (p=0.838). There was no significant difference between the subgroups (Groups 1, 2, 3, and 4) in terms of serum and HA raftlin levels. Diabetic macular edema (DME), anti-vascular endothelial growth factor (anti-VEGF), and panretinal photocoagulation (PRP) application were not found to be associated with raftlin levels in Group 3. A moderate positive correlation was found between serum and HA raftlin levels (r=0.491). There was a negative correlation between serum raftlin levels and serum glucose levels (p=0.05). No correlation was found between serum and HA raftlin levels and serum leukocyte and lipid levels (p>0.05). Conclusions: In our study, raftlin levels were examined for the first time in DM patients and it was observed that serum raftlin levels were negatively correlated with glucose levels. Raftlin molecule may be involved in the etiology of DM through VEGF.

6 January 2025 in Ankyra Medical Journal
Verified
Journal Article
Open access
PDF file
AEAbdullah Erdem
Abdullah Erdem
ABAbdullah Beyoğlu
Abdullah Beyoğlu
SDSule Acar Duyan
Sule Acar Duyan
Stem cells have been used for therapeutic purposes in many areas of medicine for many years. Depending on the tissues from which they are derived and their characteristics, stem cells can be classified into various groups. Some types of stem cells have the capacity to form an entire organism, while others can only differentiate into certain groups of tissues. In recent years, stem cells have also become popular in ophthalmology. Both stem cells found in ocular tissues and those derived from peripheral tissues are gaining attention for their use in ophthalmology. In ophthalmology, stem cells have a wide range of applications, from ocular surface and periocular tissue applications to retinal diseases. Some applications, such as limbal stem cell transplantation, have become common practices in clinical settings, while experimental and promising stem cell methods, such as anterior chamber stem cell transplants or subretinal supracoroidal stem cell transplants, are being investigated. Stem cells offer hope in ophthalmology for diseases that are unresponsive to traditional treatments, irreversible diseases, or dystrophic diseases that still lack approved treatments. The long-term effects of stem cell transplants in ophthalmology have not been clearly established, and the potential for tumor development due to uncontrolled proliferation has not been entirely eliminated. While there is a possibility of negative results from experimental studies and the emergence of concerning side effects, stem cells still hold promise as an alternative treatment option in ophthalmology.

7 July 2021 in Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Closed access
ABAbdullah Beyoğlu
Abdullah Beyoğlu
YKYalçın Karaküçük
Yalçın Karaküçük
AÇAyşegül ÇÖMEZ
Ayşegül ÇÖMEZ
AMAli Meşen
Ali Meşen
Aim: To evaluate the acute and chronic effects of smokeless tobacco (ST) on the anterior segment parameters using optical biometry. Material and Method: The comparative study included 53 right eyes of 53 subjects (study group), who used ST and 54 right eyes of 54 healthy subjects without ST (control group). Following a full ophthalmological examination, baseline measurements were taken with optical biometry and these measurements were repeated at 5, 30 and 60 mins after using ST. Central corneal thickness (CCT) (µm), anterior chamber depth (ACD) (mm), lens thickness (LT) (mm), pupillary diameter (PD) (mm), and axial length (AL) (mm) were measured. Result: No statistical difference between the control group and study group in terms of CCT, AL, ACL and LT (p=0.771, p=0.706, p=0.546, p=0.984, respectively) however, PD values were statistically significantly different (p=0.040) in baseline measurements. In the study group, similary, no statistically significant difference was determined between the measurements taken before and after ST use in respect of CCT, AL, ACD, and LT (p=0.660, p=0.058, p=0.344, p=0.059, respectively). The changes in the PD value with the use of ST were determined to be statistically significant (p<0.01). Thus, the difference in PD value was found to be statistically significant between 5 and 30 mins, between 5 and 60 mins, and between 30 and 60 mins after ST use (p<0.01, p<0.01, p<0.01 respectively). Conclusion: ST use did not show any acute and chronic effect on CCT, AL, ACD and LT. However, there was seen to be a significant effect on PD.